Skip to content
Screener

BioSig Technologies, Inc. STEX Q4 2025 Annual earnings

Reported March 31, 2026

EPS-$0.03In line
Revenue estimate$50.0K
EPS estimate-$0.03

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$300.0K
EPS estimate-$0.03

Financials

Q4 2025

Income statement

See full
Operating income-$41.6M-3,419%
Net income-$424.0M-38,481%
EPS (diluted)-$8.23-27,333%

Balance sheet

See full
Cash & equivalents$20.3M+14,207%
Total debt$38.0M+37,175%
Total equity$133.2M+8,726%
Total assets$187.5M+22,174%

Cash flow

See full
Operating cash flow-$3.0M-537%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$123.64M+381%
Enterprise value$141.34M+451%

Returns & leverage

See full
Debt / equity0.3×—
Current ratio1.7×+1.5×

FAQ

When did BioSig Technologies, Inc. report Q4 2025 earnings?
BioSig Technologies, Inc. (STEX) reported Q4 2025 earnings on March 31, 2026.
What were BioSig Technologies, Inc.'s Q4 2025 revenue and EPS?
BioSig Technologies, Inc. reported eps of $-0.03 for Q4 2025.
Did BioSig Technologies, Inc. beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.03 by $0.00.
How did BioSig Technologies, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 52.5% from $-0.06.
Where can I find BioSig Technologies, Inc.'s Q4 2025 SEC filings?
You can read the 10-K periodic report (0001493152-26-014376) directly on SEC EDGAR. The filing index links above go to sec.gov.